| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $23.4M | — | +22.1% |
| SG&A Expense | $15.6M | — | +68.4% |
| Operating Income | -$39.0M | — | -37.1% |
| Net Income | -$37.3M | — | -40.0% |
| EPS (Basic) | -$0.15 | — | -25.0% |
| EPS (Diluted) | -$0.15 | — | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.8M | +16.9% | +98.4% |
| Short-term Investments | $164.0M | -19.0% | +7.2% |
| Current Assets | $209.3M | -13.4% | +17.9% |
| Total Assets | $221.6M | -12.5% | +17.1% |
| Current Liabilities | $15.5M | -23.8% | +30.6% |
| Long-term Debt | $30.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.0M | — | -21.5% |
| Capital Expenditures | $54K | — | +1700.0% |
| Investing Cash Flow | $38.8M | — | +32.2% |
| Financing Cash Flow | -$195K | — | -108.4% |
| Free Cash Flow | -$33.1M | — | -21.7% |
| +1.8% |
| Total Liabilities | $45.6M | -9.3% | +10.0% |
| Stockholders' Equity | $176.0M | -13.3% | +19.1% |